The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients
- PMID: 25077900
- DOI: 10.1210/jc.2014-2110
The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients
Erratum in
- J Clin Endocrinol Metab. 2015 Jan;100(1):317
Abstract
Context: Mutations in CHD7, a gene previously implicated in CHARGE (coloboma, heart defect, choanal atresia, retardation of growth and/or development, genital hypoplasia, ear anomalies) syndrome, have been reported in patients presenting with Kallmann syndrome (KS) or congenital hypogonadotropic hypogonadism (CHH). Most mutations causing CHARGE syndrome result in premature stop codons and occur de novo, but the proportion of truncating vs nontruncating mutations in KS and CHH patients is still unknown.
Objective: The objective of the study was to determine the nature, prevalence, mode of transmission, and clinical spectrum of CHD7 mutations in a large series of patients.
Design: We studied 209 KS and 94 CHH patients. These patients had not been diagnosed with CHARGE syndrome according to the current criteria. We searched for mutations in 16 KS and CHH genes including CHD7.
Results: We found presumably pathogenic mutations in CHD7 in 24 KS patients but not in CHH patients. Nontruncating mutations (16 missense and a two-codon duplication) were more prevalent than truncating mutations (three nonsense, three frame shift, and a splice site), which contrasts with patients presenting with typical CHARGE syndrome. Thus, the clinical spectrum associated with CHD7 mutations may be partly explained by genotype/phenotype correlations. Eight patients also had congenital deafness and one had a cleft lip/palate, whereas six had both. For 10 patients, the presence of diverse features of the CHARGE spectrum in at least one relative argues against a de novo appearance of the missense mutation, and this was confirmed by genetic analysis in five families.
Conclusion: Considering the large prevalence and clinical spectrum of CHD7 mutations, it will be particularly relevant to genetic counseling to search for mutations in this gene in KS patients seeking fertility treatment, especially if KS is associated with deafness and cleft lip/palate.
Similar articles
-
The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome.J Clin Endocrinol Metab. 2012 May;97(5):E858-62. doi: 10.1210/jc.2011-2652. Epub 2012 Mar 7. J Clin Endocrinol Metab. 2012. PMID: 22399515
-
CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype.J Med Genet. 2011 May;48(5):334-42. doi: 10.1136/jmg.2010.087106. Epub 2011 Mar 4. J Med Genet. 2011. PMID: 21378379 Review.
-
CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene.J Med Genet. 2006 Apr;43(4):306-14. doi: 10.1136/jmg.2005.036061. Epub 2005 Sep 9. J Med Genet. 2006. PMID: 16155193 Free PMC article.
-
Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants.Genet Med. 2018 Aug;20(8):872-881. doi: 10.1038/gim.2017.197. Epub 2017 Nov 16. Genet Med. 2018. PMID: 29144511
-
The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.Mol Cell Endocrinol. 2011 Oct 22;346(1-2):74-83. doi: 10.1016/j.mce.2011.07.013. Epub 2011 Aug 2. Mol Cell Endocrinol. 2011. PMID: 21856375 Free PMC article. Review.
Cited by
-
Variations in Multiple Syndromic Deafness Genes Mimic Non-syndromic Hearing Loss.Sci Rep. 2016 Aug 26;6:31622. doi: 10.1038/srep31622. Sci Rep. 2016. PMID: 27562378 Free PMC article.
-
Digenic CHD7 and SMCHD1 inheritance Unveils phenotypic variability in a family mainly presenting with hypogonadotropic hypogonadism.Heliyon. 2023 Dec 6;10(1):e23272. doi: 10.1016/j.heliyon.2023.e23272. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38148819 Free PMC article.
-
CHD7 missense variants and clinical characteristics of Chinese males with infertility.Mol Genet Genomic Med. 2020 Sep;8(9):e1372. doi: 10.1002/mgg3.1372. Epub 2020 Jun 22. Mol Genet Genomic Med. 2020. PMID: 32573075 Free PMC article.
-
Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.Nephrol Dial Transplant. 2021 Jan 25;36(2):295-305. doi: 10.1093/ndt/gfz173. Nephrol Dial Transplant. 2021. PMID: 31738409 Free PMC article.
-
Classification of CHD7 Rare Variants in Chinese Congenital Hypogonadotropic Hypogonadism Patients and Analysis of Their Clinical Characteristics.Front Genet. 2022 Jan 3;12:770680. doi: 10.3389/fgene.2021.770680. eCollection 2021. Front Genet. 2022. PMID: 35047002 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases